小鼠延迟肩袖修复后肌内棕色脂肪激活减少肌肉萎缩与脂肪浸润并改善步态
该研究在小鼠延迟肩袖修复模型中,探讨β3肾上腺素受体激动剂amibegron通过促进棕色/米色脂肪激活对肌肉质量和前肢功能的作用。组织学显示肩袖修复后肌肉出现白色脂肪棕色化,amibegron在野生型小鼠中显著减少肌肉萎缩和脂肪浸润并恢复正常步态,但在UCP-1敲除小鼠中无效,表明其作用依赖UCP-1机制。
要点
- Amibegron在野生型小鼠中减少肩袖修复后肌肉萎缩和脂肪浸润并恢复正常步态。
- Amibegron的效应在UCP-1敲除小鼠中消失,提示作用依赖UCP-1机制。
- β3肾上腺素受体激动剂可能成为改善肩袖修复后肌肉质量的新药物策略。
核心结论
- Amibegron通过UCP-1依赖机制减少延迟肩袖修复后肌肉萎缩和脂肪浸润并改善前肢功能。
研究设计与样本
- controlled laboratory study,使用3月龄PDGFRα-GFP报告小鼠、野生型C57BL/6J小鼠和UCP-1敲除小鼠,行单侧冈上肌腱切断后6周延迟修复,假手术动物作为对照。
- Amibegron在肌腱切断后立即或修复后给予,修复后6周进行步态分析并处死取材。
主要发现
- PDGFRα报告小鼠组织学显示肩袖修复后肌肉中UCP-1表达显著增加,提示白色脂肪棕色化。
- Amibegron在肌腱切断后立即或修复后给予,均显著减少野生型小鼠肌肉萎缩和脂肪浸润并恢复正常上肢步态。
- Amibegron的效应在UCP-1敲除小鼠中不存在,提示其作用通过UCP-1依赖机制。
关键数值与推荐
- 肩袖修复后6周评估步态和组织学;amibegron在肌腱切断后立即或修复后给药。
- UCP-1敲除小鼠中amibegron效应消失,表明UCP-1依赖性。
临床怎么用
- β3肾上腺素受体激动剂可能作为治疗肩袖肌肉萎缩和脂肪浸润的新药物方式,以改善肩袖修复的临床结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Successful repair of large and massive rotator cuff (RC) tears remains a challenge at least partially because of secondary muscle atrophy and fatty infiltration. β3 Adrenergic agonists are a group of drugs that promote fat resorption through "white fat browning" of intramuscular stem cells. PURPOSE: To test the role of a β3 adrenergic receptor agonist, amibegron, in improving muscle quality and forelimb function in a delayed RC repair model via promoting brown/beige adipose tissue activation. STUDY DESIGN: Controlled laboratory study. METHODS: Three-month-old PDGFRα-GFP reporter mice, wild type C57BL/6J mice, and uncoupling protein 1 (UCP-1) knockout mice underwent unilateral supraspinatus tendon transection with a 6-week delayed tendon repair. Animals with sham surgery served as controls. Amibegron was given either immediately after tendon transection or after repair. Gait analysis was conducted to measure forelimb function at 6 weeks after tendon repair. Animals were sacrificed at 6 weeks after repair. Supraspinatus muscles were harvested and analyzed histologically. Reverse transcription polymerase chain reaction was performed to quantify gene expression related to atrophy, fibrosis, and fatty infiltration. RESULTS: Histology of PDGFRα reporter mice showed significantly increased UCP-1 expression, suggesting white fat browning in muscle after RC repair. As administered either immediately after tendon transection or after tendon repair, amibegron significantly reduced muscle atrophy and fatty infiltration and resumed normal upper extremity gait in wild type mice. However, the effect of amibegron was not present in UCP-1 knockout mice, suggesting that the effect of amibegron in treating RC muscle atrophy and fatty infiltration is through a UCP 1-dependent mechanism. CONCLUSION: Amibegron reduced muscle atrophy and fatty infiltration and improved forelimb function after delayed RC repair through a UCP 1-dependent mechanism. This may be an effective clinical treatment strategy for patients to improve muscle quality after RC repair. CLINICAL RELEVANCE: β3 Adrenergic agonists may serve as a new pharmacologic modality to treat RC muscle atrophy and fatty infiltration to improve clinical outcome of RC repair.
引用
- Wang Z, Liu X, Jiang K, et al. Intramuscular Brown Fat Activation Decreases Muscle Atrophy and Fatty Infiltration and Improves Gait After Delayed Rotator Cuff Repair in Mice. Am J Sports Med. 2020. PMID: 32282238. doi:10.1177/0363546520910421
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。